Abstract
In this paper, a research study to discover hidden knowledge in the reports of the public release of the Food and Drug Administration (FDA)’s Adverse Event Reporting System (FAERS) for erythromycin is presented. Erythromycin is an antibiotic used to treat certain infections caused by bacteria. Bacterial infections can cause significant morbidity, mortality, and the costs of treatment are known to be detrimental to health institutions around the world. Since erythromycin is of great interest in medical research, the relationships between patient demographics, adverse event outcomes, and the adverse events of this drug were analyzed. The FDA’s FAERS database was used to create a dataset for cluster analysis in order to gain some statistical insights. The reports contained within the dataset consist of 3792 (44.1%) female and 4798 (55.8%) male patients. The mean age of each patient is 41.759. The most frequent adverse event reported is oligohtdramnios and the most frequent adverse event outcome is OT(Other). Cluster analysis was used for the analysis of the dataset using the DBSCAN algorithm, and according to the results, a number of clusters and associations were obtained, which are reported here. It is believed medical researchers and pharmaceutical companies can utilize these results and test these relationships within their clinical studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shadbolt, N., O’Hara, K., Berners-Lee, T., Gibbins, N., Glaser, H.: Linked Open Government Data: Lessons from Data.gov.uk. IEEE Intelligent Systems, 1541–1672 (2012)
Boulton, G., Rawlins, M., Vallance, P., Walport, M.: Science as a public enterprise: The case for open data. The Lancet 377, 1633–1635 (2011)
Rowen, L., Wong, G.K.S., Lane, R.P., Hood, L.: Intellectual property - Publication rights in the era of open data release policies. Science 289, 1881 (2000)
Thompson, M., Heneghan, C.: BMJ OPEN DATA CAMPAIGN We need to move the debate on open clinical trial data forward. British Medical Journal, 345 (2012)
Sakaeda, T., Tamon, A., Kadoyama, K., Okuno, Y.: Data mining of the Public Version of the FDA Adverse Event Reporting System. International Journal of Medical Sciences 10(7), 796–803 (2013)
Rodriguez, E.M., Staffa, J.A., Graham, D.J.: The role of databases in drug postmarketing surveillance. Pharmacoepidemiol Drug Saf. 10, 407–410 (2001)
Wysowski, D.K., Swartz, L.: Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions. Arch Intern Med. 165, 1363–1369 (2005)
(Internet) U.S. Food and Drug Administration (FDA), http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm
(Internet) MedDRA MSSO, http://www.meddramsso.com/index.asp
Moore, T.J., Cohen, M.R., Furberg, C.D.: Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch. Intern. Med. 167, 1752–1759 (2007)
Weiss-Smith, S., Deshpande, G., Chung, S., et al.: The FDA drug safety surveillance program: Adverse event reporting trends. Arch. Intern. Med. 171, 591–593 (2011)
(Internet) Bacterial Infections, http://www.who.int/vaccine_research/diseases/soa_bacterial/en/index4.html
Manchia, M., Alda, M., Calkin, C.V.: Repeated erythromycin/codeine-induced psychotic mania. Clin. Neuropharmacol. 36(5), 177–178 (2013)
Varughese, C.A., Vakil, N.H., Phillips, K.M.: Antibiotic-associated diarrhea: A refresher on causes and possible prevention with probiotics–continuing education article. J. Pharm. Pract. 26(5), 476–482 (2013)
Chen, E.S., Hripcsak, G., Xu, H., Markatou, M., Friedman, C.: Automated Acquisition of Disease–Drug Knowledge from Biomedical and Clinical Documents: An Initial Study. J. Am. Med. Inf. Assoc. 15, 87–98 (2008)
Kadoyama, K., Sakaeda, T., Tamon, A., Okuno, Y.: Adverse event profile of Tigecycline:Data mining of the public version of the U.S. Food and Drug Administration Adverse Event Reporting System. Biological & Pharmaceutical Bulletin 35(6), 967–970 (2012)
Malla, S., Banda, S., Bansal, D., Gudala, K.: Trabectedin related muscular and other adverse effects; data from public version of the FDA Adverse Event Reporting System. Internatial Journal of Medical and Pharmaceutical Sciences 03(07), 11–17 (2013)
Raschi, E., Poluzzi, E., Koci, A., Moretti, U., Sturkenboom, M., De Ponti, F.: Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database. Journal of Pharmacovigilance 1(104), 1–4 (2013)
Harpaz, R., DuMouchel, W., Shah, N.H., Madigan, D., Ryan, P., Friedman, C.: Novel data-mining methodologies for adverse drug event discovery and analysis. Clin. Pharmacol. Ther. 91(6), 1010–1021 (2012)
Harpaz, R., Chase, H.S., Friedman, C.: Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics 11(suppl. 9), S7 (2010)
Harpaz, R., Perez, H., Chase, H.S., Rabadan, R., Hripcsak, G., Friedman, C.: Biclustering of adverse drug events in the FDA’s spontaneous reporting system. Clin. Pharmacol. Ther. 89(2), 243–250 (2011)
Vilar, S., Harpaz, R., Chase, H.S., Costanzi, S., Rabadan, R., Friedman, C.: Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: Application to rhabdomyolysis. J. Am. Med. Inform. Assoc. 18(suppl. 1) (December 2011)
Wang, X., Chase, H.S., Li, J., Hripcsak, G., Friedman, C.: Integrating heterogeneous knowledge sources to acquire executable drug-related knowledge. In: AMIA Annu. Symp. Proc. 2010, pp. 852–856 (2010)
Kadoyama, K., Miki, I., Tamura, T., Brown, J.B., Sakaeda, T., Okuno, Y.: Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations. Int. J. Med. Sci. 9(1), 33–39 (2012)
Yildirim, P., Ekmekci, I.O., Holzinger, A.: On Knowledge Discovery in Open Medical Data on the Example of the FDA Drug Adverse Event Reporting System for Alendronate (Fosamax). In: Holzinger, A., Pasi, G. (eds.) HCI-KDD 2013. LNCS, vol. 7947, pp. 195–206. Springer, Heidelberg (2013)
Belciug, S., Gorunescu, F., Salem, A.B., Gorunescu, M.: Clustering-based approach for detecting breast cancer recurrence. Intelligent Systems Design and Applications (ISDA), 533–538 (2010)
Belciug, S., Gorunescu, F., Gorunescu, M., Salem, A.: Assessing performances of unsupervised and supervised neural networks in breast cancer detection. In: 7th International Conference on Informatics and Systems (INFOS), pp. 1–8 (2010)
Emmert-Streib, F., de Matos Simoes, R., Glazko, G., McDade, S., Haibe-Kains, B., Holzinger, A., Dehmer, M., Campbell, F.: Functional and genetic analysis of the colon cancer network. BMC Bioinformatics 15(suppl. 6), S6 (2014)
Yildirim, P., Majnaric, L., Ekmekci, O., Holzinger, A.: Knowledge discovery of drug data on the example of adverse reaction prediction. BMC Bioinformatics 15(suppl. 6), S7 (2014)
Reynolds, A.P., Richards, G., de la Iglesia, B., Rayward-Smith, V.J.: Clustering rules: a comparison of partitioning and hierarchical clustering algorithms. Journal of Mathematical Modelling and Algorithms 5, 475–504 (2006)
Yıldırım, P., Ceken, K., Saka, O.: Discovering similarities fort he treatments of liver specific parasites. In: Proceedings of the Federated Conference on Computer Science and Information Systems, FedCSIS 2011, Szczecin, Poland, September 18-21, pp. 165–168. IEEE Xplore (2011) ISBN 978-83-60810-22-4
Holland, S.M.: Cluster Analysis, Department of Geology, University of Georgia, Athens, GA 30602-2501 (2006)
Hammouda, K., Kamel, M.: Data Mining using Conceptual Clustering, SYDE 622: Machine Intelligence, Course Project (2000)
Beckstead, J.W.: Using Hierarchical Cluster Analysis in Nursing Research. Western Journal of Nursing Research 24, 307–319 (2002)
Yıldırım, P., Ceken, C., Hassanpour, R., Tolun, M.R.: Prediction of Similarities among Rheumatic Diseases. Journal of Medical Systems 36(3), 1485–1490 (2012)
Han, J., Micheline, K.: Data mining: concepts and techniques. Morgan Kaufmann (2001)
Yang, C., Wang, F., Huang, B.: Internet Traffic Classification Using DBSCAN. In: 2009 WASE International Conference on Information Engineering, pp. 163–166 (2009)
Hall, M., Frank, E., Holmes, G., Pfahringe, B., Reutemann, P., Witten, I.E.: The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter 11, 1 (2009)
(internet) Drugbank, http://www.drugbank.ca
(internet) Erythromycin, http://www.drugs.com
Wang, X., Hripcsak, G., Markatou, M., Friedman, C.: Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility Study. Journal of the American Medical Informatics Association 16(3), 328–337 (2009)
(internet) Bacterial infections, http://www.nlm.nih.gov/medlineplus/bacterialinfections.html
Edwards, I.R., Aronson, J.K.: Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356(9237), 1255–1259 (2000)
(internet) Open Knowledge Foundation,Open data introduction, http://okfn.org/opendata/
(internet) http://www.chemoprofiling.org/AERS/t1.html
Poluzzi, E., Raschi, E., Piccinni, C., De Ponti, F.: Data mining techniques in Pharmacovigilance: Intech, Open Science (2012)
Holzinger, A., Dehmer, M., Jurisica, I.: Knowledge Discovery and interactive Data Mining in Bioinformatics - State-of-the-Art, future challenges and research directions. BMC Bioinformatics 15(suppl. 6), I1 (2014)
Otasek, D., Pastrello, C., Holzinger, A., Jurisica, I.: Visual Data Mining: Effective Exploration ofthe Biological Universe. In: Holzinger, A., Jurisica, I. (eds.) Interactive Knowledge Discovery and Data Mining in Biomedical Informatics: State-of-the-Art and Future Challenges. LNCS, vol. 8401, pp. 19–33. Springer, Heidelberg (2014)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Yildirim, P., Bloice, M., Holzinger, A. (2014). Knowledge Discovery and Visualization of Clusters for Erythromycin Related Adverse Events in the FDA Drug Adverse Event Reporting System. In: Holzinger, A., Jurisica, I. (eds) Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. Lecture Notes in Computer Science, vol 8401. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43968-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-43968-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43967-8
Online ISBN: 978-3-662-43968-5
eBook Packages: Computer ScienceComputer Science (R0)